Page 2 - Dermatologic Problems This News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dermatologic problems this. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dermatologic Problems This Today - Breaking & Trending Today

Dermasensor granted FDA clearance for skin cancer ID

Dermasensor Inc. received U.S. FDA clearance for its non-invasive skin cancer evaluation device that provides quantitative identification of all skin cancer types at the point of care and within seconds. The point-and-click device is designed to facilitate detection of skin cancers by primary care physicians (PCPs) and speed the time to diagnosis and treatment. ....

Dermasensor Inc , Bioworld Medtech , Dermasensor Inc , Elastic Scattering Spectroscopy ,

Lirentelimab out on failed phase II data; Allakos restructures

Allakos Inc. terminated all development of its lead drug, anti-Siglec-8 antibody lirentelimab (AK-002), and is cutting its workforce in half, following phase II failures for atopic dermatitis and chronic spontaneous urticaria. The San Carlos, Calif.-based company will now focus on phase I trials for anti-Siglec-6 antibody AK-006 as part of a restructuring that stretches the runway into mid-2026. Shares (NASDAQ:ALLK) sank by 60.2%, down $1.80, to close at $1.19 on Jan. 16. ....

Allakos Inc , San Carlos , Allakos Inc , Ak 002 , Atopic Dermatitis , Chronic Spontaneous Urticaria , Ak 006 , Require Registration , Phase Ii ,

JAK Inhibitors Are Revolutionizing Dermatology Field, Says Dr Mona Shahriari

Janus kinase (JAK) inhibitors are not only efficacious in terms of skin disease improvement, but also in terms of itch management, explained Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology. ....

Yale University , United States , Mona Shahriari , Central Connecticut Dermatology , Clinical Dermatology Conference , Case Conversations , Fall Clinical Dermatology , Jak Inhibitor ,

Biofrontera : Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz®-PDT - Form 8-K

Biofrontera Inc. , a biopharmaceutical company specializing in the commercialization of dermatologic products, announces it has engaged a contract manufacturer to develop a new, low-cost portable. | June 1, 2023 ....

United States , Tirtht Patel , Hermann Luebbert , Skin Cancer Foundation , Biofrontera Inc , Begins Development , Portable Photodynamic Therapy Lamp , Chief Executive Officer , Biofrontera Inc Stock Exchange , Press Release , Evelop Bfri Us09077d1000 ,

Biofrontera : Names Founder and Executive Chairman Hermann Luebbert as Chief Executive Officer - Form 8-K

Biofrontera Inc. , a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that its Board of Directors has named Hermann Luebbert as Chief Executive. | May 30, 2023 ....

United States , Nordrhein Westfalen , Biofrontera Bioscience Gmb , Tirtht Patel , Neuroscience Research At Novartis , University Of Cologne , Animal Physiology Department At Ruhr , California Institute Of Technology , University Bochum , Biofrontera Inc , Names Founder , Executive Chairman , Chief Executive , Hermann Luebbert , Managing Director , Neuroscience Research , Animal Physiology Department , California Institute , Biofrontera Bioscience Gmbh , Biofrontera Inc Stock Exchange , Press Release , Hief Bfri Us09077d1000 ,